Matrix proteins of basement membrane of intrahepatic bile ducts are degraded in congenital hepatic fibrosis and Caroli's disease

Journal of Pathology

Volumn 217, Issue 3, 2009, Pages 442-451

  Yasoshima, Mitsue ^a   Sato, Yasunori ^a   Furubo, Shinichi ^b   Kizawa, Kazuo ^b   Sanzen, Takahiro ^b   Ozaki, Satoru ^a   Harada, Kenichi ^a   Nakanuma, Yasuni ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b TOYAMA CHEMICAL CO LTD   (Japan)

Author keywords

Caroli's disease; Congenital hepatic fibrosis; Extracellular matrix; Plasmin; Polycystic kidney rat

Indexed keywords

ALPHA 2 ANTIPLASMIN; COLLAGEN TYPE 4; LAMININ; MATRIGEL; MATRIX PROTEIN; TISSUE PLASMINOGEN ACTIVATOR; SCLEROPROTEIN; UROKINASE;

ANIMAL CELL; ARTICLE; BASEMENT MEMBRANE; BILE DUCT CARCINOMA; CAROLI DISEASE; COLLAGEN DEGRADATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; INTRAHEPATIC BILE DUCT; KIDNEY POLYCYSTIC DISEASE; LIVER FIBROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; ANIMAL; CELL CULTURE; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CIRRHOSIS; MALE; METABOLISM; METHODOLOGY; PRENATAL DEVELOPMENT; RAT STRAIN;

ANIMALS; BASEMENT MEMBRANE; BILE DUCTS, INTRAHEPATIC; CAROLI DISEASE; CELLS, CULTURED; COLLAGEN TYPE IV; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LAMININ; LIVER; LIVER CIRRHOSIS; MALE; RATS; RATS, MUTANT STRAINS; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 60549090416     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2472     Document Type: Article

References (25)

1. Ozaki S, Sato Y, Yasoshima M, Harada K, Nakanuma Y. Diffuse expression of heparan sulfate proteoglycan and connective tissue growth factor in fibrous septa with many mast cells relate to unresolving hepatic fibrosis of congenital hepatic fibrosis. Liver Int 2005;25:817-828.
2. Nakanuma Y, Terada T, Ohta G, Kurachi M, Matsubara F. Caroli's disease in congenital hepatic fibrosis and infantile polycystic disease. Liver 1982;2:346-354.
3. Desmet VJ. Congenital diseases of intrahepatic bile ducts: variations on the theme 'ductal plate malformation'. Hepatology 1992;16:1069- 1083.
4. Crawford JM. Development of the intrahepatic biliary tree. Semin Liver Dis 2002;22:213-226.
5. Terada T, Okada Y, Nakanuma Y. Expression of matrix pro teinases during human intrahepatic bile duct development. A possible role in biliary cell migration. Am J Pathol 1995;147:1207-1213.
6. Terada T, Nakanuma Y. Expression of tenascin, type IV col lagen and laminin during human intrahepatic bile duct devel opment and in intrahepatic cholangiocarcinoma. Histopathology 1994;25:143-150.
7. Shiojiri N, Sugiyama Y. Immunolocalization of extracellular matrix components and integrins during mouse liver development. Hepatology 2004;40:346-355.
8. Andreasen PA, Egelund R, Petersen HH. The plasminogen activation system in tumor growth, invasion, and metastasis. Cell Mol Life Sci 2000;57:25-40.
9. Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 2006;25:9-34.
10. Sordat BC, Tran-Thang C. Laminin degradation by human colon carcinoma cells: a role for urinary and tissue plasminogen activators. Invasion Metastasis 1994;14:223-233.
11. Sanzen T, Harada K, Yasoshima M, Kawamura Y, Ishibashi M, Nakanuma Y. Polycystic kidney rat is a novel animal model of Caroli's disease associated with congenital hepatic fibrosis. Am J Pathol 2001;158:1605-1612.
12. Sato Y, Harada K, Kizawa K, Sanzen T, Furubo S, Yasoshima M, et al. Activation of the MEK5/ERK5 cascade is responsible for biliary dysgenesis in a rat model of Caroli's disease. Am J Pathol 2005;166:49-60.
13. Sato Y, Harada K, Furubo S, Kizawa K, Sanzen T, Yasoshima M, et al. Inhibition of intrahepatic bile duct dilation of the polycystic kidney rat with a novel tyrosine kinase inhibitor gefitinib. Am J Pathol 2006;169:1238-1250.
14. Sato Y, Harada K, Ozaki S, Furubo S, Kizawa K, Sanzen T, et al. Cholangiocytes with mesenchymal features contribute to progressive hepatic fibrosis of the polycystic kidney rat. Am J Pathol 2007;171:1859- 1871.
15. Masyuk TV, Masyuk AI, Torres VE, Harris PC, Larusso NF. Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3′,5′-cyclic monophosphate. Gastroenterology 2007;132:1104-1116.
16. Carmeliet P, Moons L, Lijnen R, Baes M, Lemaitre V, Tipping P, et al. Urokinase-generated plasmin activates matrix metallo proteinases during aneurysm formation. Nature Genet 1997; 17:439-444.
17. Lijnen HR, Van Hoef B, Lupu F, Moons L, Carmeliet P, Collen D. Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes. Arterioscler Thromb Vasc Biol 1998;18:1035-1045.
18. Lijnen HR, Silence J, Lemmens G, Frederix L, Collen D. Regu lation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system. Thromb Haemost 1998;79:1171-1176.
19. Terada T, Okada Y, Nakanuma Y. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors. Hepatology 1996;23:1341- 1344.
20. Itatsu K, Zen Y, Ohira S, Ishikawa A, Sato Y, Harada K, et al. Immunohistochemical analysis of the progression of flat and pap illary preneoplastic lesions in intrahepatic cholangiocarcinogenesis in hepatolithiasis. Liver Int 2007;27:1174-1184.
21. Shirabe K, Shimada M, Kajiyama K, Hasegawa H, Gion T, Ikeda Y, et al. Expression of matrix metalloproteinase-9 in surgically resected intrahepatic cholangiocarcinoma. Surgery 1999;126:842-846.
22. Mon NN, Hasegawa H, Thant AA, Huang P, Tanimura Y, Senga T, et al. A role for focal adhesion kinase signaling in tumor necrosis factor-alpha-dependent matrix metalloproteinase-9 production in a cholangiocarcinoma cell line, CCKS1. Cancer Res 2006;66:6778-6784.
23. Itatsu K, Zen Y, Yamaguchi J, Ohira S, Ishikawa A, Ikeda H, et al. Expression of matrix metalloproteinase 7 is an unfavorable postoperative prognostic factor in cholangiocarcinoma of the perihilar, hilar, and extrahepatic bile ducts. Hum Pathol 2008;39:710-719.
24. Sweeney WE Jr, Avner ED. Molecular and cellular pathophysiology of autosomal recessive polycystic kidney disease (ARPKD). Cell Tissue Res 2006;326:671-685.
25. Taylor AC, Palmer KR. Caroli's disease. Eur J Gastroenterol Hepatol 1998;10:105-108.